MYOLYN

What MYOLYN does

MYOLYN, Inc. is a privately held medical device company founded in 2013 in Gainesville, Florida, by Alan J. Hamlet, PhD (CEO) and Matthew Bellman, PhD (CTO) during their engineering PhD studies at the University of Florida. The company designs, engineers, assembles, and tests its products at its Florida headquarters and sells the MyoCycle family of FDA 510(k)-cleared Class II Functional Electrical Stimulation (FES) cycling therapy systems for muscle re-education. Core products include the MyoCycle Home and MyoCycle Home Plus for individual consumers, and the MyoCycle Pro and MyoCycle Pro Plus for clinical facilities, with a MyoCycle V2 variant that integrates with Zwift via Bluetooth FTMS for immersive virtual cycling. MYOLYN's differentiator is patent-pending automated calibration algorithms that customize stimulation parameters per patient without requiring specialist setup, plus automated spasm detection and the MyoPortal online patient tracking platform.

The company serves two primary customer segments. The first is home users with neurological conditions including spinal cord injury, multiple sclerosis, stroke, brain injury, and cerebral palsy, reached through a direct-to-consumer motion with website lead capture, free consultations, and comprehensive funding assistance (insurance navigation, grants, assistive technology loans, workers' compensation, and in-house financing). The second is clinical rehabilitation facilities (e.g., Shepherd Center, Craig Hospital, Kennedy Krieger/Johns Hopkins ICSCI), reached through direct enterprise sales with professional installation and in-service training. A third channel comprises VA Hospital partnerships that bring MyoCycle systems into veterans' homes. Revenue mechanics combine one-time hardware sales, a recurring electrode pad replenishment stream, optional subscription billing, and insurance/funding navigation services, with pricing kept off the public website and personalized per prospect.

MYOLYN has cumulatively delivered over 113,000 hours of exercise, 1.5 million miles cycled, and 1.4 billion muscle contractions across users in 50 U.S. states, Canada, and Australia. The company has been funded through the University of Florida, the Florida Institute for the Commercialization of Public Research, local angel investors, and a 2020 Phase 1 STTR grant. It received a patent on its novel FES cycling technology in 2020 and FDA 510(k) clearance for new MyoCycle models in 2024.

Name

MYOLYN

Legal name

MYOLYN, Inc.

Website

https://myolyn.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

MYOLYN is a privately held medical device company that designs and sells FDA-cleared Functional Electrical Stimulation (FES) cycling systems for home users and clinical facilities treating paralysis and muscle weakness from spinal cord injury, multiple sclerosis, stroke, and other neurological conditions.

Ownership category

akta.pro rank

Product category

Neurological Rehabilitation Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industries

Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Vestibular Rehabilitation & Balance Therapy (HSADAIAF)

Keywords

• Functional electrical stimulation
• Neurological rehabilitation equipment
• FES cycling therapy
• Medical cycling devices
• Muscle re-education systems

Headquarters

HQ city

Gainesville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. FES Bike Hardware Sales: Sale of MyoCycle FES cycling therapy systems including MyoCycle Home, MyoCycle Home Plus, MyoCycle Pro, and MyoCycle Pro Plus models. Each model has different feature configurations targeting home users vs. clinical facilities.
2. Subscription Billing: Monthly recurring payments for equipment through automatic recurring billing agreement with 6-month initial term and monthly renewal. Payment range provided in writing/electronically by MYOLYN representative.
3. Electrode Pad Replenishment: Replacement electrode pads sold to customers. Electrode pads typically last about one month of regular use and can be ordered through MYOLYN.
4. Insurance & Funding Navigation Services: Dedicated team helping customers obtain insurance coverage, grants, assistive technology loans, or in-house financing options. May generate service revenue through successful insurance reimbursement claims.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

MYOLYN designs, engineers, assembles, and sells FDA-cleared Functional Electrical Stimulation (FES) cycling therapy systems (the MyoCycle product family) that enable therapeutic exercise for individuals with paralysis or muscle weakness caused by spinal cord injury, multiple sclerosis, stroke, cerebral palsy, and other neurological conditions. The systems combine multi-channel FES with isokinetic cycling and feature patent-pending automatic calibration algorithms that customize stimulation parameters for each user without requiring specialist setup, supported by cloud-based progress tracking (MyoPortal) and Zwift virtual cycling integration.

Product overview

MYOLYN offers the MyoCycle FES (Functional Electrical Stimulation) Cycling Therapy System, a family of FDA-cleared medical devices for muscle re-education. The product line consists of four models: MyoCycle Home and MyoCycle Home Plus for home users, and MyoCycle Pro and MyoCycle Pro Plus for clinical facilities. All models combine FES technology with isokinetic cycling to help people with neurological disorders including spinal cord injury, multiple sclerosis, stroke, and cerebral palsy achieve therapeutic exercise. The MyoCycle V2 integrates with Zwift for immersive virtual cycling experiences. MYOLYN's proprietary technology automatically customizes muscle stimulation parameters for each patient, eliminating the need for specialized clinical setup.

Differentiator

Problem solved

Functional benefit

Brands

• MyoCycle Home: FES cycling therapy system designed for home use by individuals with paralysis, spinal cord injury, multiple sclerosis, stroke, and other neurological disorders.
• MyoCycle Home Plus
• MyoCycle Pro
• MyoCycle Pro Plus
• MyoPortal

Products and services

• MyoCycle Home Entry-level FDA-cleared FES cycling system designed for home use by individuals with paralysis or muscle weakness caused by spinal cord injury, multiple sclerosis, stroke, brain injury, or cerebral palsy. Indicated for prevention of disuse atrophy, increased local blood circulation, maintaining range of motion, relaxing muscle spasms, and muscle re-education. Features automatic calibration, simplified controls, and weekly progress reports on a 10-inch touchscreen LED display.
• MyoCycle Home Plus

Quantifiable outcome

• FDA clearance for muscle re-education, spasm prevention, circulation improvement, and range of motion maintenance
• +3 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability1 record

Feature6 records

Partnerships

Ten partnerships are on record, tiered core, flagship, notable and minor.

• ZwiftcoreTechnology or IntegrationStrategic technology partnership bringing fully immersive 3D virtual cycling to the MyoCycle V2. MYOLYN is the first and only FES cycling system integrated with Zwift, enabling users to explore virtual worlds, complete challenges, and ride with friends in real-time. This partnership drives therapy engagement and community building.
• Shepherd CenterflagshipStrategic or Co-development PartnerInnovative partnership to advance rehabilitation technology. The Shepherd Center is an internationally recognized leader in spinal cord and brain injury rehabilitation and research. Partnership involves clinical research collaboration and technology advancement in neurorehabilitation.
• Craig HospitalcoreStrategic or Co-development PartnerClinical partner spotlight featuring Craig Hospital, an internationally recognized leader in spinal cord and brain injury rehabilitation and research located in Denver, CO. Partnership involves innovative clinical use of FES cycling technology.
• VA HospitalscoreChannel Partner/ Reseller/ DistributorMYOLYN has partnered with multiple VA Hospitals across the country to bring the MyoCycle into the homes of numerous veterans. Veterans must receive medical care from a VA Medical facility to qualify for this program which provides FES therapy for service-related neurological injuries.
• Kennedy Krieger Institute / Johns HopkinsnotableStrategic or Co-development PartnerInternational Center for Spinal Cord Injury (ICSCI) at Kennedy Krieger Institute affiliated with Johns Hopkins Hospital in Baltimore, MD uses MyoCycle in patient therapy programs. Featured in patient success stories like Jimmie's recovery journey.
• First Steps Wellness CentreminorChannel Partner/ Reseller/ DistributorFES Cycling Program provider in Regina, Canada offering community FES cycling sessions using MyoCycle equipment. Program costs $100/month including initial assessment, electrodes sold separately, by appointment only.
• High Fives FoundationminorGTM or Marketing PartnerNon-profit organization providing grants and support for disabled athletes with paralysis, amputations, or other disabilities. Provides financial assistance for adaptive equipment including MyoCycle FES bikes.
• University of FloridanotableStrategic or Co-development PartnerMYOLYN spun out from University of Florida in 2013 during founders' PhD studies. Technology developed from research in biomechanics, robotics, and FES control algorithms. Supported by Florida Institute for the Commercialization of Public Research.
• Neuro and Brain Performance CentersminorChannel Partner/ Reseller/ DistributorRehabilitation clinic in Mesa, AZ offering MyoCycle FES therapy to patients. Provides neuro-rehabilitation services using guided cycling technology for neurological injuries and conditions affecting mobility.
• Amanda PerlaminorGTM or Marketing PartnerAdaptive sports athlete partnership supporting the vision to overcome neurological disorders. Amanda Perla represents MYOLYN in adaptive sports and disability community.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• ReWalk Robotics: Wearable robotic exoskeleton for individuals with spinal cord injuries; shares MYOLYN's SCI patient population and clinical rehabilitation sales channel.
• Bioness: Incumbent in the rehabilitation device space (FES, brain stimulation, orthotics); broader portfolio targeting neurological and orthopedic rehab with overlapping indications to MYOLYN's clinical customers.
• Saebo: Specialty neurorehab product company (SaeboGlove, SaeboStep, SaeboStim) serving similar clinical and home customers with stroke and SCI therapy devices, though focused more on orthotics than cycling-based FES.
• Ekso Bionics: Robotic exoskeleton and rehabilitation device company serving spinal cord injury and stroke patients in clinical rehab settings - adjacent technology but overlapping clinical buyer and reimbursement framework.
• Tyromotion: Offers robotic and sensor-based rehabilitation devices for neurological and orthopedic patients; comparable clinical customer base and rehab category overlap with MYOLYN.

Others

• Zwift: Strategic partner rather than competitor; the virtual cycling platform that MYOLYN's MyoCycle V2 integrates with, providing the engagement layer that differentiates MYOLYN from competing FES devices.
• Bertec: Provides balance, gait, and rehabilitation assessment equipment serving the same physical therapy clinics that purchase MYOLYN's clinical products.

Direct peers

• Motekforce Link: Provides computer-assisted rehabilitation including FES-integrated cycling (C-mill and M-Gait), overlapping directly with MYOLYN's clinical neurorehab use case.
• Hasomed: German manufacturer of the RehaMove FES cycling system used in neurological rehabilitation clinics and research, offering a directly overlapping product category with MYOLYN.
• Restorative Therapies: Manufacturer of the RT300 FES cycling system, the closest direct competitor to MYOLYN's MyoCycle Pro in both clinical and home rehabilitation settings for patients with spinal cord injury, stroke, and MS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/myolyn-llc-606518882823279
• Xx.com/myolyn1
• LinkedInlinkedin.com/company/myolyn

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MYOLYN